Abel Hall, LLC Generation Bio Co. Transaction History
Abel Hall, LLC
- $216 Billion
- Q2 2025
A detailed history of Abel Hall, LLC transactions in Generation Bio Co. stock. As of the latest transaction made, Abel Hall, LLC holds 23,565 shares of GBIO stock, worth $127,722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,565Holding current value
$127,722% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GBIO
# of Institutions
28Shares Held
11.4MCall Options Held
116KPut Options Held
0-
Black Rock Inc. New York, NY3.29MShares$17.9 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC828KShares$4.49 Million1.14% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL169KShares$917,4160.0% of portfolio
-
Kestra Private Wealth Services, LLC57KShares$308,9400.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ15.5KShares$83,7870.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $320M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...